Publications

Benefit-risk analysis of health benefits of routine childhood immunisation against the excess risk of SARS-CoV-2 infections during the COVID-19 pandemic in Africa.

Abbas, K; Procter, SR; VAN ZANDVOORT, K; Clark, A; FUNK, S; Mengistu, T; Hogan, D; Dansereau, E; JIT, M; FLASCHE, S;

2020

(2020). 10.1101/2020.05.19.20106278.

Parents' and guardians' views and experiences of accessing routine childhood vaccinations in England during the coronavirus (COVID-19) pandemic: cross-sectional survey and qualitative interview data.

BELL, S; Clarke, R; MOUNIER-JACK, S; PATERSON, P;

2020

, London School of Hygiene & Tropical Medicine (London, United Kingdom) (2020). 10.17037/DATA.00001861.

Clinical Development of New TB Vaccines: Recent Advances and Next Steps.

Hatherill, M; WHITE, RG; Hawn, TR;

2020

Frontiers in Microbiology, (2020).10, 10.3389/fmicb.2019.03154.

Modelling of the Epidemiological Impact, Cost-effectiveness and Budget Impact of Novel Tuberculosis Vaccines on Multidrug-resistant Tuberculosis in China.

WEERASURIYA, C; Harris, R; Gomez, GB; WHITE, R;

2020

(2020).

Impact of Community Treatment With Ivermectin for the Control of Scabies on the Prevalence of Antibodies to Strongyloides stercoralis in Children.

MARKS, M; Gwyn, S; Toloka, H; KOSITZ, C; Asugeni, J; Asugeni, R; Diau, J; Kaldor, JM; Romani, L; Redman-MacLaren, M; MacLaren, D; Solomon, AW; MABEY, DC W; Steer, AC; Martin, D;

2020

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, (2020).71 12 10.1093/cid/ciaa584.

Online vaccine-related information-seeking in mothers and HPV vaccine uptake in their daughters.

Dib, F; MAYAUD, P; Longfier, L; Launay, O;

2020

European Journal of Public Health, (2020).30 Sup 5 10.1093/eurpub/ckaa165.1254.

Zika seroprevalence declines and neutralizing antibodies wane in adults following outbreaks in French Polynesia and Fiji.

HENDERSON, AD; Aubry, M; Kama, M; Vanhomwegen, J; Teissier, A; Mariteragi-Helle, T; Paoaafaite, T; Teissier, Y; Manuguerra, J-C; EDMUNDS, J; WHITWORTH, J; Watson, CH; Lau, CL; Cao-Lormeau, V-M; KUCHARSKI, AJ;

2020

ELIFE, (2020).9, 10.7554/eLife.48460.

From cervical cancer elimination to eradication of vaccine-type human papillomavirus: Feasibility, public health strategies and cost-effectiveness.

JIT, M; PREM, K; Benard, E; Brisson, M;

2020

Preventive medicine, (2020).144, 10.1016/j.ypmed.2020.106354.

Selection of Antibody Responses Associated With Plasmodium falciparum Infections in the Context of Malaria Elimination.

Van den Hoogen, LL; STRESMAN, G; Présumé, J; Romilus, I; Mondélus, G; Elismé, T; Existe, A; Hamre, KE S; Ashton, RA; Druetz, T; Joseph, V; Beeson, JG; Singh, SK; Boncy, J; Eisele, TP; Chang, MA; Lemoine, JF; TETTEH, KK A; Rogier, E; DRAKELEY, C;

2020

Frontiers in immunology, (2020).11, 10.3389/fimmu.2020.00928.

Early impact of the coronavirus disease (COVID-19) pandemic and physical distancing measures on routine childhood vaccinations in England, January to April 2020.

MCDONALD, HI; Tessier, E; White, JM; Woodruff, M; Knowles, C; Bates, C; Parry, J; WALKER, JL; SCOTT, JA; SMEETH, L; Yarwood, J; Ramsay, M; Edelstein, M;

2020

EUROSURVEILLANCE, (2020).25 19 10.2807/1560-7917.ES.2020.25.19.2000848.